Dachaigh › Luchd-obrach › Novartis Pharmaceuticals Corporation › Senior Principal Biostatistician
Senior Principal Biostatistician aig Novartis Pharmaceuticals Corporation: Tuarastalan H-1B
23 iarrtasan cumhaichean-obrach airson an dreuchd Senior Principal Biostatistician aig Novartis Pharmaceuticals Corporation. Tuarastal bunasach meadhanach $136,219; leth meadhanach $112,965–$142,542.
Iarrtasan (LCAs)23
Tuarastal meadhanach a chaidh a thabhann$136,219
Leath mheadhanach nan tuarastalan$112,965–$142,542
Ceudail 10mh–90mh$100,010–$151,411
A rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 9 | $126,027 |
| FY2024 | 9 | $136,219 |
| FY2025 | 1 | $142,771 |
| FY2026 | 4 | $120,412 |
Iarrtasan
| Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|
| $112,965 Ìre II | East Hanover, NJ | 5 Cèit 2026 | 1 Dàmh 2026 | Dearbhaichte |
| $112,965 Ìre II | East Hanover, NJ | 9 Gibl 2026 | 1 Dàmh 2026 | Dearbhaichte |
| $144,373 Ìre III | East Hanover, NJ | 7 Gibl 2026 | 1 Dàmh 2026 | Dearbhaichte |
| $127,858 Ìre IV | Cambridge, MA | 11 Samh 2025 | 28 Màrt 2026 | Dearbhaichte |
| $142,771 Ìre III | East Hanover, NJ | 19 Màrt 2025 | 15 Sult 2025 | Dearbhaichte |
| $142,771 Ìre III | East Hanover, NJ | 12 Iuch 2024 | 1 Sult 2024 | Dearbhaichte |
| $136,219 Ìre III | East Hanover, NJ | 13 Ògmh 2024 | 13 Dùbh 2024 | Dearbhaichte |
| $136,219 Ìre III | East Hanover, NJ | 9 Gibl 2024 | 1 Dàmh 2024 | Dearbhaichte |
| $136,219 Ìre III | East Hanover, NJ | 4 Gibl 2024 | 9 Lùna 2024 | Dearbhaichte |
| $136,219 Ìre III | East Hanover, NJ | 21 Màrt 2024 | 20 Sult 2024 | Dearbhaichte |
| $167,814 Ìre IV | East Hanover, NJ | 21 Màrt 2024 | 19 Sult 2024 | Dearbhaichte |
| $136,219 Ìre III | East Hanover, NJ | 8 Màrt 2024 | 5 Sult 2024 | Dearbhaichte |
| $104,603 Ìre II | East Hanover, NJ | 1 Dùbh 2023 | 11 Dùbh 2023 | Dearbhaichte |
| $104,603 Ìre II | East Hanover, NJ | 11 Dàmh 2023 | 4 Dùbh 2023 | Dearbhaichte |
| $136,219 Ìre III | East Hanover, NJ | 8 Sult 2023 | 23 Gearr 2024 | Dearbhaichte |
| $153,171 Ìre IV | East Hanover, NJ | 17 Cèit 2023 | 1 Dàmh 2023 | Dearbhaichte |
| $98,862 Ìre II | East Hanover, NJ | 16 Cèit 2023 | 1 Dàmh 2023 | Dearbhaichte |
| $126,027 Ìre III | East Hanover, NJ | 3 Gibl 2023 | 1 Dàmh 2023 | Dearbhaichte |
| $98,862 Ìre II | East Hanover, NJ | 20 Màrt 2023 | 18 Sult 2023 | Dearbhaichte |
| $153,171 Ìre IV | East Hanover, NJ | 16 Màrt 2023 | 15 Sult 2023 | Dearbhaichte |
| $142,314 E-3 · Ìre III | East Hanover, NJ | 18 Samh 2022 | 10 Cèit 2023 | Dearbhaichte |
| $98,862 Ìre II | East Hanover, NJ | 21 Dàmh 2022 | 13 Màrt 2023 | Dearbhaichte |
| $119,496 Ìre III | Cambridge, MA | 11 Dàmh 2022 | 2 Faoi 2023 | Dearbhaichte |
Obraichean eile aig Novartis Pharmaceuticals Corporation
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).